Dr. Chagnon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
850 Southampton Ave
Norfolk, VA 23510Phone+1 757-668-9920Fax+1 757-668-9930
Education & Training
- UPMC Medical EducationFellowship, Neurodevelopmental Disabilities, 2011 - 2015
- UPMC Medical EducationResidency, Pediatrics, 2009 - 2011
- University of Rochester School of Medicine and DentistryClass of 2009
Certifications & Licensure
- VA State Medical License 2014 - 2026
- NC State Medical License 2021 - 2025
- PA State Medical License 2009 - 2015
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Clinical Trials
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
Publications & Presentations
PubMed
- 2 citationsEarly genetic testing in pediatric epilepsy: Diagnostic and cost implications.Shanna M Swartwood, Ana Morales, Kathryn E Hatchell, Chad Moretz, Dianalee McKnight
Epilepsia Open. 2024-02-01 - 38 citationsGenetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.Dianalee McKnight, Ana Morales, Kathryn E Hatchell, Sara L Bristow, Joshua L Bonkowsky
JAMA Neurology. 2022-12-01 - 10 citationsEpilepsy and Electroencephalographic Abnormalities in SATB2-Associated Syndrome.Hannah Elisabeth Smashey Lewis, Debopam Samanta, Jenny Li Örsell, Katherine A. Bosanko, Amy C. Rowell
Pediatric Neurology. 2020-04-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: